Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
Top Cited Papers
Open Access
- 18 May 2018
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 10 (2) , 57
Abstract
Lipid-based drug delivery systems, or lipidic carriers, are being extensively employed to enhance the bioavailability of poorly-soluble drugs. They have the ability to incorporate both lipophilic and hydrophilic molecules and protecting them against degradation in vitro and in vivo. There is a number of physical attributes of lipid-based nanocarriers that determine their safety, stability, efficacy, as well as their in vitro and in vivo behaviour. These include average particle size/diameter and the polydispersity index (PDI), which is an indication of their quality with respect to the size distribution. The suitability of nanocarrier formulations for a particular route of drug administration depends on their average diameter, PDI and size stability, among other parameters. Controlling and validating these parameters are of key importance for the effective clinical applications of nanocarrier formulations. This review highlights the significance of size and PDI in the successful design, formulation and development of nanosystems for pharmaceutical, nutraceutical and other applications. Liposomes, nanoliposomes, vesicular phospholipid gels, solid lipid nanoparticles, transfersomes and tocosomes are presented as frequently-used lipidic drug carriers. The advantages and limitations of a range of available analytical techniques used to characterize lipidic nanocarrier formulations are also covered.Keywords
This publication has 95 references indexed in Scilit:
- Interaction of Liposomal Formulations of Meta‐tetra(hydroxyphenyl)chlorin (Temoporfin) with Serum Proteins: Protein Binding and Liposome DestructionPhotochemistry and Photobiology, 2012
- Cellular Uptake, Intracellular Trafficking, and Cytotoxicity of NanomaterialsSmall, 2011
- Targeting kidney mesangium by nanoparticles of defined sizeProceedings of the National Academy of Sciences, 2011
- Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasoundInternational Journal of Hyperthermia, 2011
- Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein AggregatesPharmaceutical Research, 2010
- Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeabilityJournal of Angiogenesis Research, 2010
- Transdermal drug deliveryNature Biotechnology, 2008
- The effect of particle design on cellular internalization pathwaysProceedings of the National Academy of Sciences, 2008
- X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solutionQuarterly Reviews of Biophysics, 2007
- Models of primitive cellular life: polymerases and templates in liposomesPhilosophical Transactions of the Royal Society B: Biological Sciences, 2007